Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.04%…
23,880€
0,89%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.04%…
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Let’s dig into the relative performance of Hims & Hers Health (NYSE: HIMS) and its peers as we unravel the…
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed…
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Why Hims & Hers Health, Inc. (HIMS) Declined on Wednesday
The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was…
Why Hims & Hers Health, Inc. (HIMS) Declined on Wednesday
The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was…
BofA maintains Hims & Hers stock underperform with $22 target By Investing.com
BofA maintains Hims & Hers stock underperform with $22 target…
BofA maintains Hims & Hers stock underperform with $22 target By Investing.com
BofA maintains Hims & Hers stock underperform with $22 target…
Hims & Hers health CFO sells $330,081 in stock By Investing.com
Hims & Hers health CFO sells $330,081 in stock…
Hims & Hers health CFO sells $330,081 in stock By Investing.com
Hims & Hers health CFO sells $330,081 in stock…
Hims & Hers health CFO sells $330,081 in stock By Investing.com
Hims & Hers health CFO sells $330,081 in stock…
Hims & Hers health chief legal officer sells $280,314 in stock By Investing.com
Hims & Hers health chief legal officer sells $280,314 in stock…
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on wallstreetbets Subreddit Page by MostCapital5741. In…
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on wallstreetbets Subreddit Page by MostCapital5741. In this article,…
Hims & Hers Stock Gains 5.8% in 3 Months: Heres How to Play it
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late, which are…
Hims & Hers Stock Gains 5.8% in 3 Months: Heres How to Play it
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late, which are…
Hims & Hers Stock Gains 5.8% in 3 Months: Heres How to Play it
HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges…
HIMS Stock: Ready To Bounce Back From $30?
Hims & Hers Health (NYSE: HIMS), a telehealth platform, has taken a beating recently, with shares plummeting 60% from February…
BofA keeps Hims & Hers stock at underperform, target at $22 By Investing.com
BofA keeps Hims & Hers stock at underperform, target at $22…
BofA keeps Hims & Hers stock at underperform, target at $22 By Investing.com
BofA keeps Hims & Hers stock at underperform, target at $22…
BofA keeps Hims & Hers stock at underperform, target at $22 By Investing.com
BofA keeps Hims & Hers stock at underperform, target at $22…
Sell Rating for Hims & Hers Health Due to Slowing Sales Growth and Regulatory Risks
In a report released today, Allen Lutz from Bank of America Securities reiterated a Sell rating on Hims & Hers…
HIMS Stock: Ready To Bounce Back From $30?
Hims & Hers Health (NYSE: HIMS), a telehealth platform, has taken a beating recently, with shares plummeting 60% from February…
Lobbying Update: $60,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed
$60,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure…
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Apr 14, 2025--…
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it…
Hims & Hers Health Aktie: Strategischer Umbruch
New York (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von Jefferies & Co:
Glen Santangelo, Analyst von Jefferies & Co, bestätigt die…
8,601 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Bought by O Shaughnessy Asset Management LLC
O Shaughnessy Asset Management LLC bought a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free…
Truist Financial Has Lowered Expectations for Hims & Hers Health (NYSE:HIMS) Stock Price
Hims & Hers Health (NYSE:HIMS – Get Free Report) had its price target dropped by stock analysts at Truist Financial…
Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.57%…
Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.57%…
Jefferies raises Hims & Hers stock target to $25, maintains hold By Investing.com
Jefferies raises Hims & Hers stock target to $25, maintains hold…
Jefferies raises Hims & Hers stock target to $25, maintains hold By Investing.com
Jefferies raises Hims & Hers stock target to $25, maintains hold…
Hims & Hers price target raised to $25 from $21 at Jefferies
Jefferies analyst Glen Santangelo raised the firm’s price target on Hims Hers to $25 from $21 and keeps a…
Hims & Hers, at a crossroads, wants to be the Netflix of healthcare
The generic drug maker started with cheeky ads selling knockoff Viagra. Now it’s trying to fend off big drugmakers and…
Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.57%…
Hims & Hers health COO Melissa Baird sells $910,687 in stock By Investing.com
Hims & Hers health COO Melissa Baird sells $910,687 in stock…
Hims & Hers health COO Melissa Baird sells $910,687 in stock By Investing.com
Hims & Hers health COO Melissa Baird sells $910,687 in stock…
Hims & Hers health COO Melissa Baird sells $910,687 in stock By Investing.com
Hims & Hers health COO Melissa Baird sells $910,687 in stock…
Hims Weight Loss Expansion: Real Growth or Just Hype?
[content-module:CompanyOverview|NYSE:HIMS] One of the more hotly debated stocks in the market, Hims & Hers Health (NYSE: HIMS), recently made an…